Clinical trial
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients (AIR)
NCT00379418 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients (AIR)
- Lead sponsor
- Emory University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- December 31, 2009
- Enrollment
- 220 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.